SecSonar.com

Aytu BioPharma, Inc. (AYTU)

Aytu BioPharma, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Aytu BioPharma, Inc. (AYTU) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $17.8M. Revenue grew 1.8% year-over-year and free cash flow was negative at -$5.2M. This page tracks AYTU's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 102 employees · IPO Sep 25, 2008

Valuation

Valuation & price

$2.19 · as of May 17, 2026 · -24.5% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.94

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.77$2.25$1.74Jul 25Dec 25Jul 26Jul 7, 25$2.35Jul 9, 25$2.36Jul 11, 25$2.18Jul 15, 25$2.17Jul 17, 25$2.38Jul 21, 25$2.37Jul 23, 25$2.63Jul 25, 25$2.63Jul 29, 25$2.54Jul 31, 25$2.44Aug 4, 25$2.65Aug 6, 25$2.43Aug 11, 25$2.24Aug 13, 25$2.29Aug 15, 25$2.21Aug 19, 25$2.20Aug 21, 25$2.18Aug 25, 25$2.30Aug 27, 25$2.33Aug 29, 25$2.35Sep 3, 25$2.34Sep 5, 25$2.25Sep 9, 25$2.33Sep 11, 25$2.30Sep 16, 25$2.34Sep 18, 25$2.37Sep 22, 25$2.49Sep 24, 25$2.06Sep 26, 25$1.74Sep 30, 25$1.88Oct 2, 25$1.97Oct 6, 25$2.19Oct 8, 25$2.37Oct 10, 25$2.36Oct 14, 25$2.38Oct 16, 25$2.32Oct 21, 25$2.36Oct 23, 25$2.30Oct 27, 25$2.21Oct 29, 25$2.18Oct 31, 25$2.27Nov 4, 25$2.13Nov 6, 25$2.14Nov 10, 25$2.09Nov 12, 25$2.06Nov 14, 25$2.09Nov 18, 25$2.02Nov 20, 25$1.94Nov 25, 25$2.12Nov 28, 25$2.19Dec 2, 25$2.05Dec 4, 25$2.24Dec 8, 25$2.24Dec 10, 25$2.28Dec 12, 25$2.30Dec 16, 25$2.42Dec 18, 25$2.47Dec 22, 25$2.65Dec 24, 25$2.53Dec 29, 25$2.54Jan 2, 26$2.77Jan 6, 26$2.72Jan 8, 26$2.66Jan 12, 26$2.68Jan 14, 26$2.75Jan 16, 26$2.66Jan 21, 26$2.61Jan 23, 26$2.70Jan 27, 26$2.60Jan 29, 26$2.58Feb 2, 26$2.71Feb 4, 26$2.35Feb 9, 26$2.29Feb 11, 26$2.27Feb 13, 26$2.13Feb 18, 26$2.31Feb 20, 26$2.30Feb 24, 26$2.27Feb 26, 26$2.46Mar 2, 26$2.64Mar 4, 26$2.61Mar 6, 26$2.52Mar 10, 26$2.60Mar 12, 26$2.64Mar 17, 26$2.59Mar 19, 26$2.59Mar 23, 26$2.63Mar 25, 26$2.72Mar 27, 26$2.60Mar 31, 26$2.73Apr 2, 26$2.68Apr 7, 26$2.57Apr 9, 26$2.56Apr 13, 26$2.63Apr 15, 26$2.59Apr 17, 26$2.60Apr 22, 26$2.57Apr 24, 26$2.52Apr 28, 26$2.55Apr 30, 26$2.58May 4, 26$2.55May 6, 26$2.56May 8, 26$2.50May 12, 26$2.30May 14, 26$2.27May 18, 26$2.10May 20, 26$2.15May 22, 26$2.19May 28, 26$2.24Jun 1, 26$2.15Jun 3, 26$2.09Jun 5, 26$2.25Jun 9, 26$2.30Jun 11, 26$2.19Jun 15, 26$2.20Jun 17, 26$2.11Jun 22, 26$2.25Jun 24, 26$2.19Jun 26, 26$2.17Jul 2, 26$2.16
$1.7152-week range$2.90
Loading valuation history…

Fundamentals

Key fundamentals

$17.8M

Market cap

1.8%

Revenue growth (YoY)

69.0%

Gross margin

-$5.2M

Free cash flow (USD)

-$8M

Net debt

Net cash position

13.4%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$2.6MFY 2017$3.2MFY 2018$3.7MFY 2019$7.3MFY 2020$27.6MFY 2021$65.6MFY 2022$96.7MFY 2023$107.4MFY 2024$65.2MFY 2025$66.4M
$2.6M$66.4M

Free cash flow by year

2016 → 2025

FY 2016$-12.9MFY 2017$-13.9MFY 2018$-16.0MFY 2019$-13.9MFY 2020$-28.4MFY 2021$-26.0MFY 2022$-28.8MFY 2023$-5.1MFY 2024$-1.7MFY 2025$-5.2M
-$12.9M-$5.2M

Gross margin by year

2021 → 2025

FY 202144.5%FY 202252.0%FY 202362.0%FY 202475.3%FY 202569.0%
44.5%69.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventLicense Agreement TerminationJun 25, 2026Filing
  • 8-K eventEarnings ReleaseMay 13, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • 8-K eventWarrant IssuanceApr 2, 2026Filing

Questions

Frequently asked questions

What is Aytu BioPharma, Inc.'s market cap?

Aytu BioPharma, Inc. (AYTU) has a market capitalization of $17.8M.

What is AYTU's P/E ratio?

A meaningful P/E ratio is not available for AYTU — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is AYTU's price-to-book (P/B) ratio?

AYTU trades at 0.94 times book value per share.

Are insiders buying AYTU stock?

SEC Form 4 filings show no open-market insider buys at Aytu BioPharma, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

TLPH

Talphera, Inc.

$16.3M

OPTH

Optimi Health Corp.

$19.6M

COSM

Cosmos Health Inc.

$13.9M

TXMD

TherapeuticsMD, Inc.

$24.2M

BFRI

Biofrontera Inc.

$11M

YCBD

cbdMD, Inc.

$8.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.